The burgeoning popularity of retatrutide, initially for metabolic conditions, is creating significant buzz within the UK , prompting a notable shift in medication trends. Obtaining these compounds remains a complex situation , with NHS approval currently limited and private clinics offering treatment at a higher cost . Concerns are being raised reg